# Meropenem

NDC: 44567-402
Generic name: Meropenem
Labeler / Manufacturer: WG Critical Care, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230908

FDA application: NDA215212

## Active ingredients

- MEROPENEM: 2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"44567-402"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=44567-402
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=240325ba-47a8-4ad1-bcab-6772069ee790